Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/130926
Title: Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon
Author: Gambato, Martina
Caro Pérez, Noelia
González, Patricia
Cañete, Nuria
Mariño, Zoe
Lens, Sabela
Bonacci, Martín
Bartres, Concepción
Sánchez Tapias, José M. (José María)
Carrión, José A.
Forns, Xavier
Juan, Manel
Pérez del Pulgar Gallart, Sofía
Londoño, María Carlota
Keywords: Hepatitis C
Malalties cròniques
Interferó
Cirrosi hepàtica
Hepatitis C
Chronic diseases
Interferon
Hepatic cirrhosis
Issue Date: 18-Nov-2016
Publisher: Public Library of Science (PLoS)
Abstract: Real-life data showed an increased incidence of bacterial infections in patients with advanced liver disease receiving a protease inhibitor (PI)-containing antiviral regimen against hepatitis C (HCV). However, the causes of this event are unknown. We hypothesized that PIs might impair innate immune responses through the inhibition of proteases participating in the anti-bacterial functions of neutrophils and monocytes. The aims of the study were to assess phagocytic and oxidative burst capacity in neutrophils and monocytes obtained from patients receiving a PI containing-antiviral regimen, and to determine cytokine secretion after neutrophil stimulation with flagellin. Forty patients with chronic HCV (80% with cirrhosis) were enrolled in the study, 28 received triple therapy (Group A) with pegylated-interferon and ribavirin for 4 weeks followed by the addition of a PI (telaprevir, boceprevir or simeprevir), and 12 patients received an interferon-free regimen (Group B) with simeprevir and sofosbuvir. Phagocytosis and oxidative burst capacity were analyzed by flow cytometry at baseline, week 4, and week 8 of therapy. In neutrophils from Group A patients, oxidative burst rate and oxidative enzymatic activity per cell significantly decreased throughout the study period (p = 0.014 and p = 0.010, respectively). Pairwise comparisons showed a decrease between baseline and week 4 and 8 of therapy. No differences were observed after the introduction of the PI. The oxidative enzymatic activity per cell in monocytes significantly decrease during the study period (p = 0.042) due to a decrease from baseline to week 8 of therapy (p = 0.037) in patients from Group A. None of these findings were observed in Group B patients. Cytokine secretion did not significantly change during the study in both groups. In conclusion, our data suggest that the use interferon (rather than the PI) has a deleterious effect on neutrophil and monocyte phagocytic and oxidative burst capacity in this cohort of patients with HCV-related advanced liver fibrosis.
Note: Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0166631
It is part of: PLoS One, 2016, vol. 11, num. 11, p. e0166631
URI: http://hdl.handle.net/2445/130926
Related resource: https://doi.org/10.1371/journal.pone.0166631
ISSN: 1932-6203
Appears in Collections:Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
686464.pdf494.73 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons